Teratogen update: Methylene blue

Teratology

Volumn 60, Issue 1, 1999, Pages 42-48

  Cragan, Janet D ^a,b  

^a NATIONAL CENTER FOR ENVIRONMENTAL HEALTH   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLENE BLUE; TERATOGENIC AGENT;

ARTICLE; FETUS; FETUS DEATH; HEINZ BODY; HEMOLYTIC ANEMIA; HUMAN; HYPERBILIRUBINEMIA; INTESTINE ATRESIA; MAJOR CLINICAL STUDY; METHEMOGLOBINEMIA; NEWBORN; PHOTOSENSITIVITY DISORDER; PRIORITY JOURNAL; RESPIRATORY DISTRESS; SKIN DISCOLORATION; TERATOGEN TESTING; TERATOLOGY;

ABNORMALITIES, DRUG-INDUCED; ADULT; AMNIOCENTESIS; FEMALE; FETAL DEATH; HUMANS; INFANT, NEWBORN; METHYLENE BLUE; PREGNANCY; PREGNANCY TRIMESTER, SECOND; TERATOGENS;

EID: 0032799232     PISSN: 00403709     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9926(199907)60:1<42::AID-TERA12>3.0.CO;2-Z     Document Type: Article

References (87)

1. Abrams JS. 1968. Experimental intestinal atresia. Surgery 64:185-191.
2. Archer SL, Rist K, Nelson DP, DeMaster EG, Cowan N, Weir EK. 1990. Comparison of the hemodynamic effects of nitric oxide and endothelium-dependent vasodilators in intact lungs. J Appl Physiol 68:735-747.
3. Atlay RD, Sutherst JR. 1970. Premature rupture of the fetal membranes confirmed by intraamniotic injection of dye (Evans blue T-1824). Am J Obstet Gynecol 108:993-994.
4. Barber DA, Rubin JW, Zumbro GL, Tackett RL. 1995. The use of methylene blue as an extravascular surgical marker impairs vascular responses of human saphenous veins. J Thorac Cardiovasc Surg 109:21-29.
5. Beekhuis JR, De Bruijn HWA, Van Lith JMM, Mantingh A. 1992. Second trimester amniocentesis in twin pregnancies: maternal haemoglobin as a dye marker to differentiate diamniotic twins. Br J Obstet Gynaecol 99:126-127.
6. Brown G, Frankl D, Phang T. 1996. Continuous infusion of methylene blue for septic shock. Postgrad Med J 72:612-614.
7. Brüne B, Schmidt KU, Ullrich V. 1990. Activation of soluble guanylate cyclase by carbon monoxide and inhibition by superoxide anion. Eur J Biochem 192:683-688.
8. Canto MIF, Setrakian S, Petras RE, Blades E, Chak A, Sivak MV Jr. 1996. Methylene blue selectively stains intestinal metaplasia in Barrett's esophagus. Gastrointest Endosc 44:1-7.
9. Chang KSK, Zhong MZ, Davis RF. 1996. Indigo carmine inhibits endothelium-dependent and -independent vasodilation. Hypertension 27:228-234.
10. Chaudhuri G, Buga GM, Gold ME, Wood KS, Ignarro LJ. 1991. Characterization and actions of human umbilical endothelium derived relaxing factor. Br J Pharmacol 102:31-336.
11. Chitayat D, Ohel G, Marion R, Einarson TR. 1995. Spectrophotometry of amniotic fluid: a simple and rapid method for distinguishing between gestational sacs in second-trimester amniocentesis of twin pregnancies. Obstet Gynecol 86:569-571.
12. Cowett RM, Hakanson DO, Kocon RW, Oh W. 1976. Untoward neonatal effect of intraamniotic administration of methylene blue. Obstet Gynecol 48:74-75.
13. Cragan JD, Martin L, Khoury MJ, Fernhoff PM. 1993. Dye use during amniocentesis and birth defects [letter]. Lancet 341:1352-1353.
14. Cragan JD, Martin L, Waters GD, Khoury MJ. 1994. Increased risk of small intestinal atresia among twins in the United States. Arch Pediatr Adolesc Med 148:733-739.
15. Crooks J. 1982. Haemolytic jaundice in a neonate after intra-amniotic injection of methylene blue. Arch Dis Child 57:872-873.
16. Curry S. 1982. Methemoglobinemia. Ann Emerg Med 11:214-221.
17. Derom AF, Wallaert PC, Janzing HM, Derom E. 1993. Intraoperative identification of parathyroid glands with methylene blue infusion. Am J Surg 165:380-382.
18. Dolk H. 1991. Methylene blue and atresia or stenosis of ileum and jejunum [letter]. Lancet 338:1021-1022.
19. Driscoll W, Thurin S, Carrion V, Steinhorn RH, Morin FC III. 1996. Effect of methylene blue on refractory neonatal hypotension. J Pediatr 129:904-908.
20. Elias S, Gerbie AB, Simpson JL, Nadler HL, Sabbagha RE, Shkolnik A. 1980. Genetic amniocentesis in twin gestations. Am J Obstet Gynecol 138:169-173.
21. Ellis FD, Seiler JG III, Palmore MM Jr. 1995. Methemoglobinemia: a complication after fiberoptic orotracheal intubation with benzocaine spray. J Bone Joint Surg [Am] 77:937-939.
22. Erickson JC, Widmer BA. 1968. The vasopressor effect of indigo carmine. Anesthesiology 29:188-189.
23. Fineman JR, Crowley MR, Heymann MA, Soifer SJ. 1991. In vivo attenuation of endothelium-dependent pulmonary vasodilatation by methylene blue. J Appl Physiol 71:735-741.
24. Fish WH, Chazen EM. 1992. Toxic effects of methylene blue on the fetus [letter]. Am J Dis Child 146:1412-1413.
25. Flewellen EH. 1980. Hazards of intravenous indigo carmine, fluorescein, and methylene blue. Tex Med 76:49-51.
26. Gibson MT, Mangat D, Gagliano G, Wilson M, Fletcher J, Bulman J, Newman HN. 1994. Evaluation of the efficacy of a redox agent in the treatment of chronic periodontitis. J Clin Periodontol 21:690-700.
27. Glüer S. 1995. Intestinal atresia following intraamniotic use of dyes. Eur J Pediatr Surg 5:240-242.
28. Goldstein AI, Stills SM. 1983. Midtrimester amniocentesis in twin pregnancies. Obstet Gynecol 62:659-661.
29. Gruetter CA, Barry BK, McNamara DB, Gruetter DY, Kadowitz PJ, Ignarro LJ. 1979. Relaxation of bovine coronary artery and activation of coronary arterial guanylate cyclase by nitric oxide, nitroprusside and a carcinogenic nitrosoamine. J Cyclic Nucleotide Res 5:211-224.
30. Guttman FM, Braun P, Bensoussan AL, Blanchard H, Desjardins JG, Collin PP. 1975. The pathogenesis of intestinal atresia. Surg Gynecol Obstet 141:203-206.
31. Hamill PVV. 1997. Re: "Invited commentary: response to science article, 'Epidemiology faces its limits'" [letter]. Am J Epidemiol 146:527.
32. Hampl V, Tristani-Firouzi M, Weir EK, Huang JMC, Archer SL. 1996. Cyclic guanosine monophosphate as a hyperpolarizing factor. In: Vanhoutte PM, editor. Endothelium-derived hyperpolarizing factor. Amsterdam: Harwood Academic Publishers. p 153-160.
33. Hill AB. 1965. The environment and disease: association or causation? Proc R Soc Med 56:295-300.
34. Jeanty P, Shah D, Roussis P. 1990. Single-needle insertion on twin amniocentesis. J Ultrasound Med 9:511-517.
35. Jeffords DL, Lange PH, DeWolf WC. 1977. Severe hypertensive reaction to indigo carmine. Urology 9:180-181.
36. 131 labeled human serum albumin (IHSA) and T-1824. Scand J Clin Lab Invest 16:125-132.
37. Katsuki S, Arnold W, Mittal C, Murad F. 1977. Stimulation of guanylate cyclase by sodium nitroprusside, nitroglycerin and nitric oxide in various tissue preparations and comparison to the effects of sodium azide and hydroxylamine. J Cyclic Nucleotide Res 3:23-35.
38. Kennedy WF Jr, Wirjoatmadja K, Akamatsu TJ, Bonica JJ. 1968. Cardiovascular and respiratory effects of indigo carmine. J Urol 100:775-778.
39. Kidd SA, Lancaster PAL, Anderson JC, Boogert A, Fisher CC, Robertson R, Wass DM. 1996. Fetal death after exposure to methylene blue dye during mid-trimester amniocentesis in twin pregnancy. Prenat Diagn 16:39-47.
40. Kirsch IR, Cohen HJ. 1980. Heinz body hemolytic anemia from the use of methylene blue in neonates. J Pediatr 96:276-278.
41. Koga Y, Hayashida Y, Ikeda K, Inokuchi K, Hashimoto N. 1975. Intestinal atresia in fetal dogs produced by localized ligation of mesenteric vessels. J Pediatr Surg 10:949-953.
42. Lancaster PAL, Pedisich EL. 1991. High risk of intestinal atresia among twins born to older mothers [abstract]. Proceedings of the Australian Teratology Society.
43. Lancaster PAL, Pedisich EL, Fisher CC, Robertson RD. 1992. Intraamniotic methylene blue and intestinal atresia in twins [abstract]. J Perinat Med [Suppl] 20:262.
44. Lane KL, Vallera R, Washington K, Gottfried MR. 1996. Endoscopic tattoo agents in the colon: tissue responses and clinical implications. Am J Surg Pathol 20:1266-1270.
45. Lee M, Sharifi R. 1996. Methylene blue versus indigo carmine [letter]. Urology 47:783-784.
46. Link EM, Costa DC, Lane D, Blower PJ, Spittle MF. 1996. Radioiodinated methylene blue for diagnosing early melanoma metastases [letter]. Lancet 348:753.
47. Louw JH, Barnard CN. 1955. Congenital intestinal atresia: observations on its origin. Lancet 2:1065-1066.
48. Luo D, Das S, Vincent SR. 1995. Effects of methylene blue and LY83583 on neuronal nitric oxide synthase and NADPH-diaphorase. Eur J Pharmacol 290:247-251.
49. Manhes H, Shulman A, Haag T, Canis M, Demontmarin JL. 1994. Infertility due to diseased pelvic peritoneum: laparoscopic treatment. Gynecol Obstet Invest 37:191-195.
50. Marczin N, Ryan US, Catravas JD. 1992. Methylene blue inhibits nitrovasodilator- and endothelium-derived relaxing factor-induced cyclic GMP accumulation in cultured pulmonary arterial smooth muscle cells via generation of superoxide anion. J Pharmacol Exp Ther 263:170-179.
51. Marshall JJ, Wei EP, Kontos HA. 1988. Independent blockade of cerebral vasodilation from acetylcholine and nitric oxide. Am J Physiol 255:847-854.
52. Martin W, Drazan KM, Newby AC. 1989. Methylene blue but not changes in cyclic GMP inhibits resting and bradykinin-stimulated production of prostacyclin by pig aortic endothelial cells. Br J Pharmacol 97:51-56.
53. Mayer B, Brunner F, Schmidt K. 1993. Inhibition of nitric oxide synthesis by methylene blue. Biochem Pharmacol 45:367-374.
54. McEnerney JK, McEnerney LN. 1983. Unfavorable neonatal outcome after intraamniotic injection of methylene blue. Obstet Gynecol 61:35-37.
55. Moncada S, Palmer RMJ, Higgs EA. 1991. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43:109-142.
56. Moorman-Voestermans CGM, Heij HA, Vos A. 1990. Jejunal atresia in twins. J Pediatr Surg 25:638-639.
57. Moorman-Voestermans CGM, Heij HA, Vos A. 1992. Letter to the Editor. J Pediatr Surg 27:133.
58. Myatt L, Brewer A, Brockman DE. 1991. The action of nitric oxide in the perfused human fetal-placental circulation. Am J Obstet Gynecol 164:687-692.
59. Ng TY, Datta TD, Kirimli BI. 1976. Reaction to indigo carmine. J Urol 116:132-133.
60. Nicolini U, Monni G. 1990. Intestinal obstruction in babies exposed in utero to methylene blue [letter]. Lancet 336:1258-1259.
61. Okamura T, Inoue M, Toda N. 1990. Methylene blue-sensitive and -insensitive responses to sodium nitroprusside of blood vessels isolated from animals of different species. Eur J Pharmacol 183:1267-1268.
62. Orth K, Rück A, Stanescu A, Beger HG. 1995. Intraluminal treatment of inoperable oesophageal tumours by intralesional photodynamic therapy with methylene blue [letter]. Lancet 345:519-520.
63. Ower PC, Ciantar M, Newman HN, Wilson M, Bulman JS. 1995. The effects on chronic periodontitis of a subgingivally-placed redox agent in a slow release device. J Clin Periodontol 22:494-500.
64. Plunkett GD. 1973. Neonatal complications [letter]. Obstet Gynecol 41:476-477.
65. Porat R, Gilbert S, Magilner D. 1996. Methylene blue-induced phototoxicity: An unrecognized complication. Pediatrics 97:717-721.
66. Preiser JC, Lejeune P, Roman A, Carlier E, De Backer D, Leeman M, Kahn RJ, Vincent JL. 1995. Methylene blue administration in septic shock: A clinical trial. Crit Care Med 23:259-264.
67. Salaris SC, Babbs CF, Voorhees WD III. 1991. Methylene blue as an inhibitor of superoxide generation by xanthine oxidase. Biochem Pharmacol 42:499-506.
68. Schneider F, Lutun P, Hasselmann M, Stoclet JC, Tempé JD. 1992. Methylene blue increases systemic vascular resistance in human septic shock. Intensive Care Med 18:309-311.
69. Serota FT, Bernbaum JC, Schwartz E. 1979. The methylene-blue baby [letter]. Lancet 2:1142-1143.
70. Shoemaker K, Rubin J, Zumbro GL, Tackett R. 1996. Evans blue and gentian violet: alternatives to methylene blue as a surgical marker dye. J Thorac Cardiovasc Surg 112:542-544.
71. Sills MR, Zinkham WH. 1994. Methylene blue-induced Heinz body hemolytic anemia. Arch Pediatr Adolesc Med 148:306-310.
72. Soares-Da-Silva P, Caramona MM. 1988. Effects of methylene blue on the uptake, release and metabolism of noradrenaline in mesenteric arterial vessels. J Pharm Pharmacol 40:534-538.
73. Spahr RC, Salsburey DJ, Krissberg A, Prin W. 1980. Intraamniotic injection of methylene blue leading to methemoglobinemia in one of twins. Int J Gynaecol Obstet 17:477-478.
74. + channels. Biochim Biophys Acta 1285:123-126.
75. Tabsh K. 1990. Genetic amniocentesis in multiple gestation: a new technique to diagnose monoamniotic twins. Obstet Gynecol 75:296-298.
76. Troche BI. 1989. The methylene blue baby [letter]. N Engl J Med 320:1756-1757.
77. Van de Voorde J, Vanderstichele H, Leusen I. 1987. Release of endothelium-derived relaxing factor from human umbilical vessels. Circ Res 60:517-522.
78. Van der Pol JG, Wolf H, Boer K, Treffers PE, Leschot NJ, Hey HA, Vos A. 1992. Jejunal atresia related to the use of methylene blue in genetic amniocentesis in twins. Br J Obstet Gynaecol 99:141-143.
79. Vincer MJ, Allen AC, Evans JR, Nwaesei C, Stinson DA. 1987. Methylene-blue-induced hemolytic anemia in a neonate. Can Med Assoc J 136:503-504.
80. White JJ, Esterly JR, Tecklenberg P, Haller JA. 1971. Effect of changing concepts upon the diagnosis and management of intestinal atresia. Am Surg 37:34-43.
81. Wieding JU, Hellstern P, Köhler M. 1993. Inactivation of viruses in fresh-frozen plasma. Ann Hematol 67:259-266.
82. Wolf DA, Scheible FW, Young PE, Matson MR. 1979. Genetic amniocentesis in multiple pregnancy. J Clin Ultrasound 7:208-210.
83. Wolin MS, Cherry PD, Rodenburg JM, Messina EJ, Kaley G. 1990. Methylene blue inhibits vasodilation of skeletal muscle arterioles to acetylcholine and nitric oxide via the extracellular generation of superoxide anion. J Pharmacol Exp Ther 254:872-876.
84. Yallampalli C, Izumi H, Byam-Smith M, Garfield RE. 1994. An L-arginine-nitric oxide-cyclic guanosine monophosphate system exists in the uterus and inhibits contractility during pregnancy. Am J Obstet Gynecol 170:175-185.
85. Yang CC, Hwang SF, Chou MM, Deng JF. 1995. Metobrumuron/metachlor ingestion with late onset methemoglobinemia in a pregnant woman successfully treated with methylene blue. J Toxicol Clin Toxicol 33:713-716.
86. Young JD, Dyar OJ, Xiong L, Zhang J, Gavaghan D. 1994. Effect of methylene blue on the vasodilator action of inhaled nitric oxide in hypoxic sheep. Br JAnaesth 73:511-516.
87. Young PE, Carson KF, Prichard LL, Jones OW. 1974. A technique for obtaining precise chromosome and bilirubin studies on amniotic fluid in twin pregnancy. J Reprod Med 13:163-166.